Literature DB >> 15255232

Ganglion cell death in rat retina by persistent intraocular pressure elevation.

Do Hyun Kim1, Hwa Sun Kim, Myung Douk Ahn, Myung Hoon Chun.   

Abstract

Glaucoma is characterized by loss of retinal ganglion cells (RGCs) and their axons. Retrograde axoplasmic transport blockade and excitotoxicity were proposed to be a major cause of RGC apoptosis. We conducted this study to characterize the episcleral vessel cauterization glaucoma model in the rat with respect to decreased retrograde axoplasmic flow and subsequent apoptotic RGC death. After episcleral vessels were cauterized in Sprague-Dawley rats, Fluorogold was injected into their superior colliculi by stereotactic method. Retrograde axoplasmic flow and TUNEL-stained apoptotic dead cells were observed microscopically. Elevated intraocular pressure was maintained for up to 6 weeks during follow-up. Retrograde axoplasmic flow to the rat retina was significantly decreased. Apoptotic RGC was selectively TUNEL-stained in the retina, especially at the ganglion cell layers. We concluded that elevated intraocular pressure caused apoptotic RGC death through retrograde axoplasmic flow blockage. Further studies will elucidate the neuroprotection strategies in glaucoma patients.

Entities:  

Mesh:

Year:  2004        PMID: 15255232     DOI: 10.3341/kjo.2004.18.1.15

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  6 in total

1.  Longitudinal outcomes of circumlimbal suture model-induced chronic ocular hypertension in Sprague-Dawley albino rats.

Authors:  Yamunadevi Lakshmanan; Francisca Siu Yin Wong; Bing Zuo; Bang Viet Bui; Henry Ho-Lung Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-07-05       Impact factor: 3.117

2.  Stimulation of prostaglandin EP2 receptors on RGC-5 cells in culture blunts the negative effect of serum withdrawal.

Authors:  Kui Dong Kang; B L S Andrade da Costa; N N Osborne
Journal:  Neurochem Res       Date:  2010-02-24       Impact factor: 3.996

3.  Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes.

Authors:  Anna Kipfer-Kauer; Stuart J McKinnon; Beatrice E Frueh; David Goldblum
Journal:  Curr Eye Res       Date:  2010-09       Impact factor: 2.424

Review 4.  Gene therapy targeting glaucoma: where are we?

Authors:  Xuyang Liu; Carol A Rasmussen; B'ann T Gabelt; Curtis R Brandt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

Review 5.  Target-Derived Neurotrophic Factor Deprivation Puts Retinal Ganglion Cells on Death Row: Cold Hard Evidence and Caveats.

Authors:  Marie Claes; Lies De Groef; Lieve Moons
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

Review 6.  Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies.

Authors:  Oriane Rabesandratana; Olivier Goureau; Gaël Orieux
Journal:  Front Neurosci       Date:  2018-09-20       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.